This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with interest the article of Sais et al¹ in a recent issue of the ARCHIVES that reports on an investigation into risk factors for systemic involvement in cutaneous leukocytoclastic vasculitis (CLV) and the probability of its long-term course. We believe that some basic difficulties exist in identifying the prognostic factors in CLV. The first is the potential association with a certain number of systemic diseases and factors that we are aware of and others that we still do not know. The second is the variable level of activity of CLV in chronic forms, which is often not related to the activity of the associated condition. The third is the interference of previous or present medications.

It is assumed that in many cases the cutaneous lesions histologically showing leukocytoclastic vasculitis develop without clinical or biological signs of systemic involvement. In a limited number of cases, CLV is associated with . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?